ReviewTopics in current chemistry (Cham)2026
Harnessing Organocatalysis for Enantioselective Chromane Synthesis.
Review in Topics in current chemistry (Cham), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Visible light promoted chalcone transformations and their prominence for the synthesis of functionalized molecules: a review.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chromanes are privileged scaffolds in medicinal chemistry because they exhibit diverse biological activities. Their stereoselective synthesis has become a critical objective in drug development. The emergence of organocatalysis has sparked a paradigm shift in synthetic chemistry by offering a highly selective alternative to traditional metal-catalyzed reactions. This review discusses the transformative impact of organocatalyzed reactions on the asymmetric synthesis of chromane derivatives, focusing on key classes of catalysts such as chiral phosphoric acid, chiral amines, bifunctional systems, and others reported since 2020. Organocatalysis not only achieves high levels of stereocontrol but also adheres to the principles of green chemistry by eliminating toxic metals and enabling mild reaction conditions. These advancements diversify synthetic methodologies and establish organocatalysis as a fundamental approach in the sustainable synthesis of bioactive chromanes.
Indexed as
Identifiers
42151657What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.